UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000044672 |
|---|---|
| Receipt number | R000051018 |
| Scientific Title | Comparative Efficacy and Safety of Tezepelumab and Dupilumab in Patients with Inadequately Controlled Asthma According to Thresholds of Type 2 Inflammatory Biomarkers: A Systematic Review and Network Meta-Analysis |
| Date of disclosure of the study information | 2021/06/28 |
| Last modified on | 2022/01/24 16:19:54 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2021/06/27 11:40:32 | ||
| 2 | Update | 2021/08/01 15:12:10 | Public title Public title Acronym Acronym Scientific Title Scientific Title Scientific Title:Acronym Scientific Title:Acronym |
|
| 3 | Update | 2021/08/01 15:15:31 | Other related information Other related information |
|
| 4 | Update | 2021/12/27 09:17:58 | Recruitment status Date of IRB |
|
| 5 | Update | 2022/01/24 15:57:12 | Public title Scientific Title |
|
| 6 | Update | 2022/01/24 15:58:34 | Key secondary outcomes Key secondary outcomes |
|
| 7 | Update | 2022/01/24 16:17:18 | Key inclusion criteria Key inclusion criteria Key exclusion criteria Key exclusion criteria |
|
| 8 | Update | 2022/01/24 16:19:54 | Number of participants that the trial has enrolled |
